Description
The abstract proposes that Parkinson’s disease originates in the gut and spreads to the CNS through the vagus nerve, but the precise molecular pathways mediating this gut-to-brain transmission remain unexplained. Understanding these mechanisms is critical for developing targeted interventions that could prevent disease progression.
Gap type: unexplained_observation Source paper: The gut-brain axis in Parkinson’s disease. (2024, Revue neurologique, PMID:38129277)
Resolution criteria
Resolution requires: (1) Alpha-synuclein preformed fibril (PFF) injection into the duodenal wall of mice with intact vs. vagotomized vagus nerve, demonstrating >=70% reduction in brainstem/nigral pS129-alpha-syn propagation after vagotomy (confirming vagal route); (2) Identification of the molecular carrier or receptor mediating gut-to-brain transit: co-immunoprecipitation or proximity ligation assay in enteric nervous system tissue identifying at least one receptor (e.g., TLR2, LAG3, APLP1) required for alpha-syn uptake by vagal afferents, with knockdown or antibody blockade reducing transmission by >=50%; (3) Human post-mortem evidence: quantitative comparison of Lewy body density in dorsal motor nucleus of vagus vs. substantia nigra in early vs. late-stage PD (n>=30) supporting caudal-to-rostral progression gradient. Correlation of gut dysbiosis with PD without mechanistic pathway evidence is insufficient.